EDYTHE BOITNOTT: Open Payments
NPI 1780718973 · DANVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,391 in 79 payments from 22 companies in 2025. Trend: 2023 $2,045 · 2024 $2,219 · 2025 $1,391
Food & beverage: $1,391
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $495 |
| UCB, Inc. | 7 | $136 |
| Lundbeck LLC | 5 | $109 |
| ARGENX US, INC. | 4 | $88 |
| Neurelis, Inc. | 3 | $68 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Mallinckrodt Hospital Products Inc. | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| Lilly USA, LLC | 2 | $38 |
| PFIZER INC. | 2 | $37 |
Products named: QULIPTA, UBRELVY, VYEPTI, VYVGART HYTRULO, VALTOCO, BOTOX, Rystiggo, ACTHAR.
Industry payments across VA — which companies pay providers there.
